EDP-788

DRUG2 trials

Sponsors

Enanta Pharmaceuticals, Inc

Conditions

HealthySafety in Normal Volunteers

Phase 1

Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

CompletedNCT01999725

Enanta Pharmaceuticals, IncSafety in Normal Volunteers

Start: 2014-01-31End: 2014-09-30Updated: 2015-01-09

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788

TerminatedNCT02255968

Enanta Pharmaceuticals, IncHealthy

Start: 2014-08-31End: 2014-10-31Updated: 2015-05-12